Literature DB >> 35427638

A Prussian blue alginate microparticles platform based on gas-shearing strategy for antitumor and antibacterial therapy.

Xiaoli Zhang1, Qingli Qu1, Weixia Cheng2, Aying Zhou1, Yankang Deng1, Wenjing Ma1, Miaomiao Zhu1, Ranhua Xiong3, Chaobo Huang4.   

Abstract

Prussian blue (PB) with distinct hollow mesoporous structure and favorable properties has captured the attention of extensive biomaterial researchers. However, there is an unmet need for biocompatible PB microparticles with recyclability fabricated by a facile method. Herein, a size-controlled PB alginate microparticles (PBAMs) generated by a one-step and large batch production gas-shearing strategy. With the characteristic of porous and surface-modifiable, PBAMs used as vehicles may effectively load and release drug to improve the therapeutic efficacy. Meanwhile, Fe2+ in PBAMs exerts a catalyze for chemodynamic therapy (CDT) to produce reactive oxygen species (ROS), which synergizes with the photothermal therapy (PTT) induced by PB particles with effective photothermal conversion, achieving active tri-modality combination antitumor and antibacterial. The new concept for the low-cost and facile preparation of biocompatible PBAMs here illustrated opens a novel pathway toward the effective multifunctional platform.
Copyright © 2022. Published by Elsevier B.V.

Entities:  

Keywords:  Antibacterial; Antitumor; Gas-shearing strategy; Prussian blue alginate microparticles; Tri-modality combination therapy

Mesh:

Substances:

Year:  2022        PMID: 35427638     DOI: 10.1016/j.ijbiomac.2022.04.064

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  1 in total

1.  Biocompatible curcumin coupled nanofibrous membrane for pathogens sterilization and isolation.

Authors:  Yuanyuan Rao; Shasha Feng; Ze-Xian Low; Junwei Wu; Shengui Ju; Zhaoxiang Zhong; Weihong Xing
Journal:  J Memb Sci       Date:  2022-08-10       Impact factor: 10.530

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.